SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Arvind Remedies shines on commencing commercial operation of new unit in Tamil Nadu

26 Feb 2014 Evaluate

Arvind Remedies is currently trading at Rs. 43.20, up by 0.40 points or 0.93% from its previous closing of Rs. 42.80 on the BSE.

The scrip opened at Rs. 43.30 and has touched a high and low of Rs. 43.70 and Rs. 43.15 respectively. So far 6276 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 59.95 on 08-Nov-2013 and a 52 week low of Rs. 24.85 on 01-Mar-2013.

Last one week high and low of the scrip stood at Rs. 44.90 and Rs. 42.50 respectively. The current market cap of the company is Rs. 296.69 crore.

The promoters holding in the company stood at 36.31% while Institutions and Non-Institutions held 0.06% and 63.63% respectively.

Arvind Remedies has commenced commercial operation of the new unit at Kakkalur, Tiruvellore in Tamil Nadu. Earlier, the company had signed a Memorandum of Understanding (MoU) with four institutions to manufacture and market medicines from botanical source, which are useful for the treatment and management of Neuro-degeneration disorder (like alzheimer, parkinson) and Neuropsychiatry disorders (like depression). The four educational institutions with whom the company had inked MoU are Banaras Hindu University, Adesh University, SRM University and Genome Foundation.

Arvind Remedies is engaged in the manufacturing of pharmaceutical formulations such as tablets, capsules (including soft gels), ointments and liquids. ARL markets its products in the institutional (primarily government organizations) and ethical segments, with institutional segment contributing to 70% of the total revenues.

Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×